Gender differences in PTSD severity and pain outcomes: baseline results from the LAMP trial

Background: Post-traumatic stress disorder (PTSD) and chronic pain are highly prevalent comorbid conditions. Veterans dually burdened by PTSD and chronic pain experience more severe outcomes compared to either disorder alone. Few studies have enrolled enough women Veterans to test gender differences in pain outcomes [catastrophizing, intensity, interference] by the severity of PTSD. Aim: Examine gender differences in the association between PTSD symptoms and pain outcomes among Veterans enrolled in a chronic pain clinical trial. Methods. Participants were 421 men and 386 women Veterans with chronic pain who provided complete data on PTSD symptoms and pain outcomes. We used hierarchical linear regression models to examine gender differences in pain outcomes by PTSD symptoms. Results. Adjusted multivariable models indicated that PTSD symptoms were associated with higher levels of pain catastrophizing (0.57, 95% CI [0.51, 0.63]), pain intensity (0.30, 95% CI [0.24, 0.37]), and pain interference (0.46, 95% CI [0.39, 0.52]). No evidence suggesting differences in this association were found in either the crude or adjusted models (all interaction p-values<0.05). Conclusion: These findings may reflect the underlying mutual maintenance of these conditions whereby the sensation of pain could trigger PTSD symptoms, particularly if the trauma and pain are associated with the same event. Clinical implications and opportunities testing relevant treatments that may benefit both chronic pain and PTSD are discussed.

effects by gender (32).The current study assesses whether gender differences exist in association between PTSD symptoms and pain outcomes in a comparative sample of men and women Veterans.
This manuscript reports the associations between probable PTSD symptoms and three dimensions of chronic pain outcomes: pain catastrophizing (negative thinking about one's pain), pain intensity (how strong the pain feels), and pain interference (how one experiences pain, pain interference with daily activities), in a sample of U.S. Veterans diagnosed with a chronic pain condition.Specifically, we assessed gender differences in the association between probable PTSD and chronic pain outcomes.Based on the higher prevalence of both PTSD and chronic pain among women Veterans, the study team hypothesized that gender differences would be present across strata of probable PTSD and chronic pain outcomes.This study extends previous research on the associations between PTSD and chronic pain due to the unique gender composition of our data, which includes approximately equal numbers of men and women Veterans with chronic pain.

Methods Study design and sample
This is a secondary analysis of Veterans randomized for participation in the Learning to Apply Mindfulness to Pain (LAMP) study (n=811).The LAMP study was a three-arm, multi-site, randomized pragmatic trial designed to assess the efficacy of multimodal delivery of two mindfulness-based interventions compared to usual care for Veterans with chronic pain at one of the three participating sites.Participants were recruited from the Minneapolis, Durham, and Greater Los Angeles Veterans Affairs Healthcare Systems.To be eligible, participants needed to have: 1) at least two qualifying pain diagnoses within the same pain category on at least two separate occasions at least 90 days apart during the previous two years documented in their electronic health record (EHR), 2) a pain duration of at least six months, a pain severity score of at least four during the previous week on a Likert scale of 0-10, and 3) access to a smartphone and the internet.Participants were excluded if they had: 1) new diagnoses of schizophrenia, for use under a CC0 license.This article is a US Government work.It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint this version posted October 15, 2023.; https://doi.org/10.1101/2023.10.13.23296998 doi: medRxiv preprint bipolar disorder, major depressive disorder, current psychotic symptoms, suicidality, or other psychosis within the past 18 months (assessed by chart review); or 2) were currently enrolled in another pain study or a Mindfulness-Based Stress Reduction (MBSR) program (assessed by survey).Participants were recruited between November 4, 2020 and May 25, 2022.Participants provided verbal consent, which was recorded in the study tracking database by the study recruitment coordinator.Additional study details are described in the protocol paper (33).
Of the participants (n=1945) who met eligibility criteria, 1,737 completed the baseline survey, and 811 were randomized to one of the intervention arms.Due to an a priori study aim to examine gender differences, women were oversampled and comprised 48% of participants.Measures Predictors PTSD symptoms were assessed using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) (34).The PCL-5 is a 20-item self-report measure that assesses the presence and severity of PTSD symptoms over the past month (range, 0-80).Respondents are asked to rate how bothered they have been by each of the 20 items on a five-point Likert scale.Response options for all items are: "Not at all" (0), "A little bit" (1), "Moderately" (2), "Quite a bit" (3), or "Extremely" (4).Items are summed with scores of 31 or higher, indicating probable PTSD and a need for additional clinical assessment or PTSD treatment (35).PCL-5 scores were standardized and parameterized as continuous in the analysis.Outcomes Pain Catastrophizing was assessed using the Pain Catastrophizing Scale (PCS) (36).The PCS is a 13item self-report instrument that asks respondents to reflect on past painful experiences and indicate their thoughts and feelings in response to pain (range, 0-52).Response options for all items are: "Not at all" (0), "To a slight degree" (1), "To a moderate degree" (2), "To a great degree" (3), or "All the time" (4).
for use under a CC0 license.This article is a US Government work.It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint this version posted October 15, 2023.; https://doi.org/10.1101/2023.10.13.23296998 doi: medRxiv preprint Items are summed with scores of 30 or higher, representing a clinically significant level of pain catastrophizing (36).PCS scores were standardized and parameterized as continuous in analysis.Pain intensity and interference.The Brief Pain Inventory (BPI) subscales were used to assess participant experiences of pain intensity (range, 0-10) and interference (range, 0-10) during the past week (37,38).Pain interference was assessed by seven items asking the extent to which pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on an 11-point numeric rating scale from "Does not interfere" (0) to "Completely interferes" (10).Pain intensity was assessed by four items asking participants to rate their worst, least, average, and current pain severity for the past 1 month on an 11-point numeric rating scale from "No pain" (0) to "Pain as bad as you can imagine" (10).BPI subscale scores were standardized and parameterized as continuous in analysis (39).Covariates Gender was identified by self-report on the study screening questionnaire.Answer options included: man, woman, another gender, and decline to answer.Participants who identified as either "another gender" or "decline to answer" were then re-coded for analysis using their administrative birth-sex as reported in EHR.Sociodemographic variables included self-identified racial identity ("White," "African American or Black," "American Indian/Alaskan Native," "Asian," Native Hawaiian/Pacific Islander," and "Multiracial"); ethnicity ("Hispanic or Latino" and "Not Hispanic or Latino"), highest level of educational attainment ("High school or less," "Some college," "Bachelor's degree," and "Master's degree or beyond"), and age.The patient facility where participants were recruited (Minneapolis, Durham, or Greater Los Angeles VA Medical Centers) was also included in adjusted models.Analysis for use under a CC0 license.This article is a US Government work.It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint this version posted October 15, 2023.; https://doi.org/10.1101/2023.10.13.23296998 doi: medRxiv preprint First, we conducted descriptive analyses summarizing distributions of all variables overall and stratified by gender identity (Table 1).Crude and sociodemographic adjusted linear regression models were used to quantify the association between PTSD symptoms and each pain outcome (pain catastrophizing, intensity, and interference).We fit two sets of models (crude and adjusted) models to assess the association between PTSD symptoms and each pain outcome.We additionally assessed effect measure modification by gender (whether the association between PTSD symptoms and each pain outcome differed by gender identity) by adding an interaction term to each model.Due to differences in the scale range of all outcomes, all estimates were standardized to represent the number of standard deviations of change in each pain outcome associated with a one standard deviation change in the exposure variable, PTSD symptoms.Statistical significance was assessed at alpha level p<0.05.All statistical analyses were conducted using Stata 17 (College Station, TX).

Participant Characteristics
A total of 807 participants provided complete data on PTSD, pain catastrophizing, pain intensity, and pain interference on the baseline survey (n=807/811).Women in our sample were more likely to be employed, have four-year or more advanced degrees, be a member of a racially minoritized group, and be younger compared to men.Mean and standard deviations of scores for all outcome variables are also shown in Table 1.Women reported statistically significant higher mean scores for all pain outcomes and PTSD symptoms compared to men.  2 shows the standardized estimates, 95% confidence intervals (CI), and results from the regression models examining the association between PTSD symptoms and pain outcomes (catastrophizing, intensity, and interference).Results are shown for both the crude and the model adjusted for sociodemographic characteristics.Results from the adjusted models indicated that PTSD symptoms were associated with higher levels of pain catastrophizing (0.57, 95% CI [0.51, 0.63]), pain intensity for use under a CC0 license.
The present study provides a unique contribution to the existing literature due to the size and approximately equal proportions of men and women Veterans that allowed tests of heterogeneity of effects in this association by gender.The ability to investigate gender differences regarding pain and PTSD in previous Veteran samples has been hampered by poor recruitment and retention of women in VA clinical trials, which typically average only 3-22% women (32,44).The lack of gender differences, may reflect the underlying mechanism of the mutual maintenance model whereby the sensation of pain could trigger PTSD symptoms (intrusions, avoidance, arousal), particularly if the trauma and pain are associated with the same event and this mechanism operates similarly in men and women (28,45).In the case of pain catastrophizing, this may reflect the tendency to magnify the threat value of pain, thereby increasing feelings of helplessness and difficulty inhibiting pain-related thoughts (46).Alternatively, the lack of gender differences in these associations may be in part due to the restriction that all Veterans in the current analysis needed to meet inclusion criteria for entry into the LAMP clinical trial, which may make them more similar compared to the overall Veteran patient population.Eligibility criteria for this clinical trial screened out those with recent diagnosis of a mental disorder (e.g., depression, suicidality), which may have resulted in a clinical sample that is less psychiatrically severe compared to a typical sample of Veterans seeking chronic pain care.These restrictions may obscure gender differences present in more psychiatrically severe patients with comorbid chronic pain conditions.
Elevated levels of pain catastrophizing, intensity, and interference in people with probable PTSD, highlight the need for interdisciplinary care modalities to target both PTSD and chronic pain symptoms.There have been mixed results regarding the efficacy of cognitive-based therapies in reducing comorbid PTSD and pain, with interventions generally demonstrating greater reduction in PTSD symptoms with little change in pain interference and intensity (41,(47)(48)(49).Mindfulness-based therapies have demonstrated reductions in both PTSD and chronic pain outcomes, indicating their promise as an for use under a CC0 license.This article is a US Government work.It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint this version posted October 15, 2023.; https://doi.org/10.1101/2023.10.13.23296998 doi: medRxiv preprint effective treatment for people with comorbid PTSD and chronic pain (50)(51)(52)(53)(54). Finally, Veterans with comorbid chronic pain and PTSD may specifically benefit from integrated and trauma-informed treatment modalities that recognize the mutually reinforcing relationship between PTSD and pain (55).As the VA continues to develop and test multimodal care for Veterans with comorbid trauma and pain conditions, careful attention will be required to evaluate gender-sensitive treatment options (e.g.integrated into women's clinic, online options) to ensure women Veterans feel comfortable accessing the required care to address these highly co-prevalent conditions (56,57).
This study contributes to the literature by assessing associations between probable PTSD and pain outcomes as well as findings related to gender differences in a Veteran population with highly prevalent PTSD and comorbid chronic pain.Some limitations must be considered when interpreting our results.First, our sample may differ from civilian samples in important ways.For example, compared to civilian samples, Veterans with chronic pain have higher average levels of PTSD symptoms (8).Additionally, we were unable to account for gender differences in the onset of trauma across the life-course (e.g., Adverse Childhood Experience, sexual assault, service-related exposures), where the timing, frequency, and severity may relate to the onset of chronic pain symptoms.Finally, this analysis was conducted on a sample of participants who volunteered to participate in a mindfulness study for chronic pain.Therefore, findings may not generalize to the broader population of Veterans with chronic pain.Despite these limitations, our study has several strengths, including completeness of data, including survey and electronic health record data from a large, diverse, and balanced sample of Veterans with chronic pain.Finally, this uniquely large and gender-balanced study cohort of Veterans allowed for analyses into potential gender differences in pain outcomes by the presence of probable PTSD.

Conclusion
This study found that PTSD symptoms were associated with elevated levels of pain catastrophizing, pain intensity, and pain interference in women and men Veterans.We did not find any statistically significant gender differences in the associations between PTSD symptoms and pain for use under a CC0 license.This article is a US Government work.It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint this version posted October 15, 2023.; https://doi.org/10.1101/2023.10.13.23296998 doi: medRxiv preprint outcomes.The unique gender composition of this sample created an opportunity to test these differences, addressing a limitation present in other Veteran samples.Our results contribute to research in Veterans aimed at understanding shared underlying mechanisms of this co-morbidity and testing relevant treatments that may concurrently benefit both chronic pain and PTSD.